Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis

Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients. Rituximab is a monoclonal antibody against CD20 antigen that is expressed in mature and immature B cells. Early experience with rituximab su...

Full description

Bibliographic Details
Main Authors: Tülay Şimşek, Nilgün Yıldırım, Belgin Efe, Nur Kebapçı
Format: Article
Language:English
Published: Galenos Yayinevi 2017-01-01
Series:Türk Oftalmoloji Dergisi
Subjects:
Graves’ orbitopathy
rituximab
psoriasis
Online Access:http://www.oftalmoloji.org/article_14247/Rituximab-Treatment-In-A-Patient-With-Active-Graves-Orbitopathy-And-Psoriasis

Similar Items

Similar Items